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patients at increased risk of postoperative pulmonary
complications
LAS VEGAS - an observational study in 29 countries
The LAS VEGAS investigatorsMBACKGROUND Limited information exists about the
epidemiology and outcome of surgical patients at increased
risk of postoperative pulmonary complications (PPCs),
and how intraoperative ventilation was managed in these
patients.
OBJECTIVES To determine the incidence of surgical
patients at increased risk of PPCs, and to compare the
intraoperative ventilation management and postoperative
outcomes with patients at low risk of PPCs.
DESIGN This was a prospective international 1-week obser-
vational study using the ‘Assess Respiratory Risk in Surgical
Patients in Catalonia risk score’ (ARISCAT score) for PPC
for risk stratification.
PATIENTS AND SETTING Adult patients requiring intra-
operative ventilation during general anaesthesia for surgery
in 146 hospitals across 29 countries.
MAIN OUTCOME MEASURES The primary outcome
was the incidence of patients at increased risk of PPCs
based on the ARISCAT score. Secondary outcomes
included intraoperative ventilatory management and clinical
outcomes.ht © European Society of Anaesthesiology. Un
his article is accompanied by the following Invited Com
aller G, Walder B. Postoperative pulmonary complication
4:489–491.
rrespondence to Marcus J. Schultz, MD, PhD, Department of Intensive Care, C3-425
Amsterdam, The Netherlands
mail: marcus.j.schultz@gmail.com
he LAS VEGAS (Local ASsessment of VEntilatory management during Gene
gital Content (http://links.lww.com/EJA/A119).
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wnload and share the work provided it is properly cited. The work cannot be changed inRESULTS A total of 9864 patients fulfilled the inclusion
criteria. The incidence of patients at increased risk was
28.4%. The most frequently chosen tidal volume (VT) size
was 500 ml, or 7 to 9 ml kg1 predicted body weight, slightly
lower in patients at increased risk of PPCs. Levels of positive
end-expiratory pressure (PEEP) were slightly higher in
patients at increased risk of PPCs, with 14.3% receiving
more than 5 cmH2O PEEP compared with 7.6% in patients
at low risk of PPCs (P<0.001). Patients with a predicted
preoperative increased risk of PPCs developed PPCs more
frequently: 19 versus 7%, relative risk (RR) 3.16 (95%
confidence interval 2.76 to 3.61), P<0.001) and had longer
hospital stays. The only ventilatory factor associated with the
occurrence of PPCs was the peak pressure.
CONCLUSION The incidence of patients with a predicted
increased risk of PPCs is high. A large proportion of
patients receive high VT and low PEEP levels. PPCs occur
frequently in patients at increased risk, with worse clinical
outcome.
TRIAL REGISTRATION The study was registered at Clin-
icaltrials.gov, number NCT01601223.
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Mechanical ventilation with positive pressure can cause
overdistension as well as repetitive opening and collapse
of lung units, which can induce or worsen existing lung
injury.1 In critically ill patients with acute respiratory
distress syndrome (ARDS) who need ventilatory support,
ventilation strategies that use lower tidal volumes (VT)
have been found to be beneficial.2 Recent studies show
that critically ill patients without ARDS who require
mechanical ventilation could benefit from this strategy.3,4
Ventilation strategies that use higher levels of positive
end-expiratory pressure (PEEP) have also been found to
improve outcome in patients with ARDS.5 Worldwide,
these findings have led to significant changes in venti-
lation practice in critically ill patients.6,7
Theoretically, surgical patients with uninjured lungs could
also benefit from intraoperative ventilation strategies that
use low VT and higher PEEP levels.
8 Indeed, three recent
randomised controlled trials in patients scheduled for
major abdominal surgery showed that intraoperative venti-
lation with low VT as part of a lung-protective ventilation
strategy reduced the occurrence of postoperative pulmon-
ary complications (PPCs).9–11 The debate on the best
PEEP level during intraoperative ventilation, however,
is ongoing.12,13 Notably, one meta-analysis of recent
randomised controlled trials suggests that it is intraopera-
tive VT restriction rather than an increase in PEEP level
that was responsible for the benefits observed.14
Attempts to improve outcomes in surgical patients by
preventing PPCs may be a more effective strategy than
treating PPCs once they occur.15 With an estimated
worldwide number of surgical procedures more than
234 million each year, even a small reduction in the
incidence of PPCs could have a significant effect.16
Epidemiologic data suggest that PPCs are rarely present
shortly after surgery, but in a subset of patients at
increased risk, PPCs develop over a period of days with
considerable impact on outcome.17,18 Although this
particular group of patients at increased risk of PPCs
would benefit most from lung-protective ventilation, the
current management of lung ventilation in these patients
is unknown. Neither is it known if ventilation strategies
differ between patients at high or low risk of PPCs.
Therefore, we undertook the ‘Local ASsessment of VEnti-
latory management during General Anaesthesia for
Surgery’ (LAS VEGAS) study to determine the incidence
of patients at increased risk of PPCs, and to compare
ventilation management and outcomes in patients at
increased risk of PPCs with patients at low risk of PPCs.
Methods
Study design
The LAS VEGAS study was an international, multicen-
tre, prospective cross-sectional study. The study protocol
was first approved by the ethical committee of theyright © European Society of Anaesthesiology. UAcademic Medical Center, Amsterdam, the Netherlands
(W12_190#12.17.0227). Surgical patients were enrolled
over a period of 7 consecutive days between 14 January
and 4 March 2013. National coordinators selected the
exact period during which data were collected for the
study in their respective countries.
Study sites were recruited through the Clinical Trial
Network of the European Society of Anaesthesiology
(ESA), providing access to a large network of
anaesthesiologists. The participating hospitals represen-
ted a convenient sample of those that initially agreed to
participate in the study. Each site was then required to
seek approval to implement this protocol from their
respective institutional review boards and, if required,
to obtained written informed consent from individual
patients or their legal representatives.
The ESA assisted in developing the electronic case
record forms and hosted the electronic database, but
had no influence on the study design, conduct, data
analysis and interpretation, or on the final reporting.
Quality control
National coordinators assisted local coordinators to
ensure that the study was performed according to the
‘International Conference on Harmonisation (Good
Clinical Practice)’ guidelines.19 Local coordinators
arranged regulatory approvals, supervised local research-
ers, and assured the integrity of the data and its timely
collection. Patient data were entered into a password
secured, web-based electronic case record form (Open-
Clinica, Boston, Massachusetts, USA) and was anon-
ymised before entry. Two rounds of extensive data
cleaning were performed before the start of data analysis
to check for outliers and possible invalid data. Local
investigators were queried on incorrect data, then asked
to verify the data in the patient records, and correct the
electronic form.
Inclusion and exclusion criteria
All adult patients receiving invasive ventilation (via
either an endotracheal tube or supraglottic device) during
general anaesthesia for elective or non-elective surgery
were included. Patients were excluded from participation
if they were aged less than 18 years, or scheduled for
pregnancy-related surgery, surgical procedures outside
the operating room, or procedures involving cardiopul-
monary bypass. Data from patients undergoing thoracic
surgery, or who required one-lung ventilation during
surgery, and those who had received ventilation at any
time in the previous 30 days were collected, but excluded
from the current analysis.
Data collection
Centres with large patient numbers, defined as more than
180 surgical procedures per week, could request and werenauthorized reproduction of this article is prohibited.
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randomly select either 25 or 50% of their eligible patients
for inclusion using the ALEA software (ALEA Version
2.2; NKIAVL, Amsterdam Netherlands). The randomis-
ation procedure is further described in the Supplemental
Digital Material, http://links.lww.com/EJA/A119.
Based on the literature, we collected baseline character-
istics and preoperative risk factors that help to identify
patients at risk of PPCs.20–22 During the intraoperative
period we collected data on intraoperative ventilator
settings and vital parameters hourly, and recorded intrao-
perative events possibly related to mechanical venti-
lation. PPCs were observed and collected daily from
the day of surgery (day 0) until discharge from hospital
or postoperative day 5, whichever came first. Length of
hospital stay and in-hospital mortality was collected by
examination of patient records at postoperative day 28.
Definitions
The risk of PPCs was based on preoperative data and
defined retrospectively by the ‘Assess Respiratory Risk in
Surgical Patients in Catalonia risk score for PPCs’ (ARIS-
CAT score). For the purpose of this study, moderate-risk
and high-risk groups (ARISCAT scores 26 to 44 and45,
respectively) were combined into a group called
‘increased risk of PPCs’ (ARISCAT score 26) (eTable
1, http://links.lww.com/EJA/A119).17,18 Of note, clini-
cians providing care were not informed a priori on use
of the ARISCAT score for stratification of patients.
Intraoperative events included episodes of hypoxia
(SpO2< 92%), use of lung recruitment manoeuvres
(ventilation strategies aimed to restore aeration of the
lungs); airway pressure reduction (ventilation strategies
aimed to lower peak and plateau pressure), presence of
expiratory flow limitation (expiratory flow higher than
zero at end-expiration as suggested by visual analysis of
the expiratory gas flow curve), hypotension (systolic
arterial blood pressure <90 mmHg for 3 min or longer),
use of vasoactive drugs (any given to correct hypoten-
sion), and new arrhythmias (atrial fibrillation, sustained
ventricular tachycardia, supraventricular tachycardia, or
ventricular fibrillation).
PPCs were defined as unplanned supplementary
oxygen (oxygen administered due to PaO2< 8 kPa or
SpO2< 90% in room air, but excluding oxygen supple-
mentation given as standard care, e.g. directly after arrival
in the postanaesthetic care unit), respiratory failure
(PaO2< 8 kPa or SpO2< 90% despite oxygen therapy,
or a need for noninvasive positive pressure ventilation
(NIPPV); unplanned new or prolonged invasive mech-
anical ventilation (after discharge from the operating
room), ARDS (defined according to the Berlin definition
of ARDS),23 pneumonia (presence of a new or progres-
sive radiographic infiltrate and at least two of three
clinical features; fever >388C or >100.48F, leucocytosisight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2017; 34:492–507or leukopenia (WBC count >12 000 cellsml3 or
<4000 cellsml3 and purulent secretions), and pneu-
mothorax (air in the pleural space with no vascular bed
surrounding the visceral pleura on the chest radiograph).
Outcomes
The primary outcome was the incidence of patients at
increased risk of PPC. Secondary outcomes included
ventilatory management, namely VT (ml kg
1 predicted
body weight, PBW), level of PEEP (cmH2O), VT-PEEP
combinations, number of intraoperative events, number
of PPCs developing in the first 5 postoperative days,
length of hospital stay, and in-hospital mortality. A com-
posite endpoint was calculated for the PPCs observed
from the day of surgery (day 0) until hospital discharge or
postoperative day 5, whichever came first. Each adverse
pulmonary event was recorded on days 1 to 5, and was
scored ‘YES’ as soon as the event occurred on either ward
or intensive care unit. If the event was present on
subsequent days, it was not scored again.
Analysis plan
Part of the statistical analysis plan was published pre-
viously in this journal.24 We planned to include only data
from centres that had more than 95% of complete and
reliable data with regard to VT size (i.e. in ml and in
ml kg1 PBW) and PEEP levels.
Patients were stratified into groups based on the retro-
spectively applied ARISCAT score: preoperative low risk
(ARISCAT score <26) or increased risk of PPCs (ARIS-
CAT score 26).17 The proportion of patients at
increased risk of PPCs was calculated by dividing the
number of patients with increased preoperative risk of
PPCs by the total number of patients. The number of
patients at increased risk of PPCs per surgical procedure
over the study period was calculated by dividing the
number of patients with increased risk of PPCs divided
by the number of total surgical procedures performed in
this cohort. The ventilatory data, which were collected
hourly, were first averaged for each patient before being
included in the whole population data analysis. The data
are presented for the whole population and for patients at
low versus increased risk for PPCs. Length of hospital
stay and in-hospital mortality was censored at postopera-
tive day 28.
The distributions of combinations of VT size and PEEP
level, VT size and respiratory rate, and VT size and peak
pressure level, are presented in scatterplots. Cut-offs of
8 ml kg1 PBW for VT, 5 cmH2O for PEEP, 20 cmH2O for
peak pressure, and 14 bpm for respiratory rate were
chosen to form the matrices. These cut-offs were based
on widely accepted values of each variable, or according
to normal daily practice. The driving pressure, defined as
plateau pressure (Pplat) minus the PEEP level, was
analysed following the same analysis plan as for the other
ventilatory parameters. The driving pressure analysis wasauthorized reproduction of this article is prohibited.
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VT size and driving pressure level combinations were
plotted in one extra scatterplot, in which the median
driving pressure (12 cm H2O) was used as a cut-off to
build the matrix.
Finally, we compared ventilator settings in patients who
did and did not develop PPCs. A multivariable model was
built to quantify the net effect of intraoperative venti-
lation settings on the occurrence of PPCs, while control-
ling for other demographic and perioperative data.20–22
In one post-hoc analysis we restricted the composite
endpoint of PPCs to severe PPCs, by ignoring
‘unplanned supplementary oxygen’. In a second post-
hoc analysis, in an attempt to provide more insight into
the effects of stratification using the three original
ARISCAT risk groups, we analysed the data according
to the original boundaries, that is, ARISCAT score less
than 26, 26 to 44, and at least 45.
We strictly followed the Strengthening the Reporting of
Observational Studies in Epidemiology (STROBE)
statement guidelines for observational studies (provided
in the supplemental digital material, pp. 11 to 13, http://
links.lww.com/EJA/A119).
Statistical analysis
All variables were tested for normality using Kolmo-
gorov–Smirnov–Lilliefors. Hourly collected variables,
including VT size, PEEP level, peak and plateau pressure
levels, respiratory rate, oxygen fraction of inspired air
(FiO2), are presented as medians with their interquartile
ranges. VT size is presented as an absolute volume (ml)
and volume normalised for PBW (ml kg1 PBW). The
PBW was calculated as 50þ 0.91 (height [cm] 152.4)
for men, and 45.5þ 0.91 (height [cm] 152.4) for
women.23 Parametric data are presented as means (with
standard deviations), whereas non-parametric data are
presented as medians [with the 25th and 75th percen-
tiles]. To clarify missing data in the calculations, we
report the number of cases with specific outcome data
(n) along with the total number of relevant cases (N) for
all variables. We reported the n/N on all variables, to be
transparent on reporting of missing data.
Proportions are compared usingx2 or Fisher exact tests and
continuous variables are compared using the t test or Wil-
coxon rank-sum test, as appropriate. Adjustments for
multiplecomparisonswerenotperformed for thepreopera-
tive and intraoperative characteristics. Kaplan–Meier esti-
mates of the cumulative probability of development of
PPCs and survival were performed. We used log-rank tests
to compare survival distributions in patients at low risk or
increased risk of PPCs. Patients discharged from the hos-
pital before the end of follow-up at day 28 were assumed
alive and without complications at this time point.
To build the multivariable model, independent variables
were selected from the demographic and perioperativeyright © European Society of Anaesthesiology. Udata according to biologic plausibility and when a P value
less than 0.2 was found in the univariable analysis. Peak
pressure, plateau pressure, and driving pressure had high
collinearity; therefore, only peak pressure was entered
into the model, as plateau pressure had missing values.
Effects were expressed as an average odds ratio (OR)
with 95% confidence interval (95% CI). In the model,
statistical significance was set at a P value< 0.05. Stat-
istical significance was considered to be at P< 0.05. All
analyses were performed with R version 3.1 (http://www.
R-project.org/).
Results
Participating centres and patients
Of 219 centres that expressed an initial interest in parti-
cipating in the LAS VEGAS study, 73 (in seven
countries) were unable to obtain formal approval from
their local institutional review board in time, or had other
reasons not to participate (Fig. 1). The 146 hospitals
taking part in the study were recruited from 30 different
countries (eTable 2, http://links.lww.com/EJA/A119).
The list of countries, participating centres, and their
respective numbers of included patients are presented
in eTable 2, http://links.lww.com/EJA/A119. Hospital
characteristics of participating centres are given in
eTable 3, http://links.lww.com/EJA/A119. Only two
centres used the randomisation program to reduce the
number of patients – one to reduce the number of
patients to 50% and one to reduce the number of patients
to 25% of eligible patients.
In total 10 520 patients requiring intraoperative venti-
lation were enrolled. After exclusion of patients under-
going one-lung ventilation and patients who had received
mechanical ventilation before surgery, 9864 patients of
the complete cohort were available for analysis. Sufficient
data to calculate the ARISCAT score retrospectively
were available in 9413. Patient and surgical character-
istics are shown in Table 1 and eTable 4, http://links.
lww.com/EJA/A119.
Incidence of patients at increased risk of postoperative
pulmonary complications
Patients at increased risk of PPCs represented 2670 of
9413 patients ventilated for surgery or 28 cases per 100
surgical procedures over one week among all types of
procedure. Patients undergoing transplant surgery or
aortic surgery had the highest incidence of PPCs of all
types of surgical procedures (Table 2).
Intraoperative ventilation characteristics
The most frequently chosen VT was 500 ml, which cor-
responds to a VT between 7.2 and 9.1 ml kg
1 PBW.
Patients at increased risk of PPCs received higher VT
(ml kg1 PBW) than those at low risk of PPCs, but the
differences were of minimal clinical significance
(Table 3, Fig. 2a). VT was >8 ml kg
1 PBW in 43% ofnauthorized reproduction of this article is prohibited.
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Fig. 1
219 centres expressed interest
146 centres participated
73 centres excluded:
656 patients excluded:
451 patients excluded for analysis:
− IRB did not approve:1
− IRB approval obtained too late:15
− lack of personnel: 13
− other preasons: 12
− no reason: 32
− Thoracic surgery: 302
− Recent ventilation before surgery: 354
− Insufficient data to calculate ARISCAT score
10 520 subjects enrolled
9864 patients with
intraoperative data
9413 patients in ARISCAT
score analysis
Flow chart: Data collection and selection of centres and patients. Two centres used the optional randomisation program to reduce the number of
patients: one centre reduced the patient numbers by 50% (excluding 75 patients) and another centre by 75% (excluding 307 patients). ARISCAT,
Assess Respiratory Risk in Surgical Patients in Catalonia; IRB, institutional review board.patients at increased risk of PPCs vs. 40% of patients at
low risk of PPCs. PEEP levels were 5 cmH2O or less in
most patients, and the most frequently chosen PEEP
levels were 0 or 5 cmH2O. Compared with patients at low
risk of PPCs, patients at increased risk of PPCs received
higher PEEP levels but again, this difference was of
minimal clinical significance (Table 3, Fig. 2b).
Anaesthetists generally used volume-controlled venti-
lation and the pressure support mode or combined modes
of ventilation were seldom used (Table 3). Patients
at increased risk of PPCs were ventilated at similar
respiratory rates, but were ventilated with higher peak
pressures (Table 3, Fig. 2c). Recruitment manoeuvres
were applied more often in patients at increased risk of
PPCs. The driving pressure was only calculable in
patients in whom the plateau pressure was reported
(60% of all patients). Driving pressure levels were
higher in patients at increased risk of PPCs, but again
the difference from patients at low risk was minimal
(Table 3, Fig. 2d).ight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2017; 34:492–507Distributions of combinations of ventilation settings are
presented in Fig. 3. A VT 8 ml kg
1 or less PBW in
combination with PEEP levels more than 5 cmH2O
was used in a minority of patients, and was not different
between the two risk groups. The combination of low
respiratory rates with high VT was more often used in
patients at increased risk of PPCs (Fig. 3d).
Patient outcomes
Patients at increased risk of PPCs more frequently devel-
oped intraoperative events (35.3 versus 23.7%, RR 2.01
(95% CI 1.83 to 2.20), P< 0.001) and PPCs (19.2 versus
7.0%, RR 3.16 (95% CI 2.76 to 3.61), P< 0.001) (Tables 4
and 5). The most frequent intraoperative event was
hypotension (Table 4). The most frequent PPCs were
unplanned supplemental oxygen, followed by respiratory
failure, and need for invasive mechanical ventilation
(Table 5). Severe PPCs, defined as total PPCs excluding
unplanned supplemental oxygen, occurred in 2.8% of all
patients and in 14.5 versus 1.6% (RR 3.98 (95% CI 3.09 to
5.12), P< 0.001), of patients at increased versus low riskauthorized reproduction of this article is prohibited.
Copyright © European Society of Anaesthesiology. Unauthorized reproduction of this article is prohibited.
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Table 1 Patient and surgical baseline characteristics within each group
Variable All patients Low risk of PPCs Increased risk of PPCs
Male sex (%) 45.0 (4439/9864) 43.6 (2937/6743) 48.5 (1294/2670)
Age (years) (%) 53.0 [39.0 to 66.0] 50.0 [36.0 to 63.0] 62.0 [50.0 to 72.0]
50 45.0 (4440/9861) 52.1 (3510/6742) 25.5 (680/2669)
51 to 80 51.0 (5033/9861) 46.1 (3111/6742) 65.2 (1741/2669)
>80 3.9 (388/9861) 1.8 (121/6742) 9.3 (248/2669)
BMI (kg m2) 26.2 [23.4 to 30.0] 26.0 [23.2 to 29.7] 26.8 [23.7 to 30.7]
ASA physical status classification system
ASA 1 30.6 (3013/9840) 36.3 (2445/6734) 14.0 (373/2663)
ASA 2 48.2 (4743/9840) 49.1 (3305/6734) 47.0 (1252/2663)
ASA 3 19.3 (1903/9840) 13.8 (929/6734) 34.5 (919/2663)
ASA 4 1.8 (173/9840) 0.8 (53/6734) 4.3 (115/2663)
ASA 5 0.1 (8/9840) 0.0 (2/6734) 0.2 (4/2663)
Functional status
Non dependent 92.4 (9105/9858) 94.7 (6385/6739) 86.5 (2308/2669)
Partially dependent 6.3 (621/9858) 4.3 (291/6739) 11.5 (307/2669)
Totally dependent 1.3 (132/9858) 0.9 (63/6739) 2.0 (54/2669)
ARISCAT score 15.0 [3.0 to 26.0] 11.0 [3.0 to 16.0] 34.0 [31.0 to 41.0]
<26 71.6 (6743/9413) 100.0 (6743/6743) -
26 to 44 23.5 (2215/9413) - 83.0 (3315/2670)
>44 4.8 (455/9413) - 17.0 (455/2670)
Preoperative SpO2 (%) 98.0 [96.0 to 99.0] 98.0 [97.0 to 99.0] 97.0 [95.0 to 98.0]
96 83.4 (7254/8698) 90.2 (5450/6043) 65.9 (1609/2440)
91 to 95 15.3 (1331/8698) 9.8 (591/6043) 29.5 (721/2440)
90 1.3 (113/8698) 0.0 (2/6043) 4.5 (110/2440)
Preoperative anaemia (Hb  10 g dl1) 4.0 (329/8265) 1.0 (53/5573) 10.5 (265/2528)
Chronic comorbidity – a patient can have more than one comorbidity
Metastatic cancer 4.0 (392/9864) 1.8 (124/6743) 9.7 (260/2670)
Chronic kidney dysfunction 3.1 (310/9864) 2.0 (137/6743) 6.1 (162/2670)
COPD 6.0 (596/9864) 4.8 (322/6743) 9.6 (256/2670)
Heart failure 5.9 (585/9864) 4.6 (313/6743) 9.6 (255/2670)
Obstructive sleep apnoea 2.1 (205/9864) 2.0 (132/6743) 2.5 (68/2670)
Neuromuscular diseaseb 0.9 (88/9864) 1.0 (66/6743) 0.8 (21/2670)
Liver dysfunction 1.0 (102/9864) 0.8 (54/6743) 1.6 (43/2670)
Surgical procedure – a patient can have more than one type of surgical procedure
Lower GI 11.1 (1096/9864) 6.9 (466/6743) 21.7 (579/2670)
Upper GI, hepatobiliary, pancreas 13.8 (1357/9864) 11.2 (753/6743) 21.3 (568/2670)
Vascular surgerya 3.1 (309/9864) 2.9 (197/6743) 3.7 (99/2670)
Aortic surgery 0.6 (64/9864) 0.3 (18/6743) 1.7 (45/2670)
Neurosurgery, head and neck 20.3 (2006/9864) 3.1 (1558/6743) 12.8 (342/2670)
Urological and kidney 8.7 (858/9864) 6.7 (455/6743) 13.8 (368/2670)
Gynaecological 11.6 (1141/9864) 10.9 (733/6743) 12.9 (345/2670)
Endocrine surgery 2.0 (194/9864) 2.4 (159/6743) 1.1 (30/2670)
Transplant 0.3 (34/9864) 0.1 (5/6743) 1.0 (28/2670)
Plastic, cutaneous, breast 10.5 (1037/9864) 13.1 (885/6743) 4.2 (113/2670)
Bone, joint, trauma, spine 16.2 (1595/9864) 18.6 (1253/6743) 9.6 (255/2670)
Other procedure 5.9 (585/9864) 7.2 (483/6743) 3.0 (79/2670)
Surgical technique – a patient can have more than one type of surgical procedure
Open abdominal surgery 18.0 (1773/9864) 7.6 (512/6743) 44.8 (1195/2670)
Laparoscopic surgery 17.6 (1737/9864) 16.0 (1082/6743) 22.0 (587/2670)
Laparoscopic assisted surgery 1.7 (167/9864) 1.1 (73/6743) 3.4 (90/2670)
Peripheral surgery 18.5 (1827/9864) 22.2 (1500/6743) 8.2 (218/2670)
Other 44.9 (4427/9864) 53.3 (3594/6743) 23.5 (628/2670)
Urgency of surgeryc
Elective 88.9 (8765/9862) 91.1 (6141/6742) 84.2 (2248/2670)
Urgent 8.6 (845/9862) 7.5 (508/6742) 10.8 (288/2670)
Emergency 2.6 (252/9862) 1.4 (93/6742) 5.0 (134/2670)
Duration of surgery (min)d 73.0 [42.0 to 125.0] 60.0 [35.0 to 95.0] 131.0 [75.0 to 199.0]
Duration of anaesthesia (min)e 103.0 [66.0 to 160.0] 90.0 [60.0 to 128.0] 170.0 [107.0 to 246.0]
Data are presented as median [LQ to UQ] or % (n/N); low versus increased risk of PPCs, according to the Assess Respiratory Risk in Surgical Patients in Catalonia
(ARISCAT) risk score (<26 versus 26, respectively). ASA, American Society of Anaesthesiology; COPD, chronic obstructive pulmonary disease; GI, gastrointestinal;
Hb, haemoglobin; LQ, lower quartile; UQ, upper quartile; n, number with characteristic; PPC, postoperative pulmonary complication; N, number in group or subgroup;
SpO2, peripheral oxygen saturation.
a Vascular surgery is carotid endarterectomy, aortic surgery and peripheral vascular taken together. b Neuromuscular disease affecting
the respiratory system. c Urgency of surgery: elective: surgery that is scheduled in advance because it does not involve a medical emergency, urgent: surgery required
within<48 h, emergency: nonelective surgery performed when the patient’s life or well being is in direct jeopardy. d Duration of surgery is the time between skin incision and
closure of the incision. e Duration of anaesthesia is the time between start of induction and tracheal extubation or discharge from operation room if mechanical ventilation
continued.
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Table 2 Surgical procedure and incidence of postoperative
pulmonary complications
Surgical procedure
Incidence
of PPC
Incidence of
severe PPC
Lower GI 16.1 (177/1096) 6.5 (71/1096)
Upper GI, hepatobiliary, pancreas 13.0 (177/1357) 5.0 (68/1357)
Vascular surgerya 11.9 (37/309) 3.9 (12/309)
Aortic surgery 20.3 (13/64) 10.9 (7/64)
Neurosurgery, head and neck 7.7 (154/2006) 1.9 (38/2006)
Urological and kidney 11.4 (98/858) 2.4 (21/858)
Gynaecological 9.2 (105/1141) 1.4 (17/1141)
Endocrine surgery 10.3 (20/194) 3.6 (7/194)
Transplant 38.2 (13/34) 5.9 (2/34)
Plastic, cutaneous, breast 6.7 (69/1037) 1.6 (17/1037)
Bone, joint, trauma, spine 10.3 (165/1595) 1.8 (29/1595)
Other procedure 7.9 (46/585) 1.9 (11/585)
All data are presented as proportion, % (n/N); a patient could have had more than
one type of surgical procedure within one operation (e.g. neurosurgery and
trauma). GI, gastrointestinal; n, number with characteristic; N, number in group or
subgroup; PPC, postoperative pulmonary complication. a Vascular surgery is
carotid endarterectomy, aortic surgery and peripheral vascular taken together.of PPCs, respectively (eTable 5, http://links.lww.com/
EJA/A119). Patients at increased risk of PPCs had higher
in-hospital mortality rates (1.7 versus 0.2%, RR 8.07 (95%ight © European Society of Anaesthesiology. Un
Table 3 Intraoperative ventilation characteristics
All patients
Ventilation mode
Volume control 70.1 (6816/9717)
Pressure control 16.2 (1571/9717)
Pressure support or spontaneous 1.1 (104/9717)
Othera 12.6 (1226/9717)
Airway type
Endotracheal tube 81.8 (8064/9857)
Nasotracheal tube 1.3 (127/9857)
Supraglottic device 15.9 (1570/9857)
Other 1.0 (96/9857)
Tidal volumes (ml) 500.0 [455.0 to 558.5] 5
Tidal volumes ml kg1 PBW 8.1 [7.2 to 9.1]
Tidal volumes ml kg1 ABW 6.7 [5.8 to 7.7]
PEEP (cmH2O) 3.5 [0.0 to 5.0]
Respiratory rate (bpm) 12.0 [12.0 to 13.0]
Minute ventilation (ml min1) 6000 [5000 to 6769]
Ppeak (cmH2O) 17.5 [15.0 to 21.0]
Pplat (cmH2O) 15.5 [13.0 to 18.5]
Driving pressure (cmH2O) 12.0 [10.0 to 15.0]
Cdyn (ml cm1 H2O) 34.8 [28.1 to 42.8]
Cq.stat. (ml cm1 H2O) 41.7 [33.4 to 51.4]
Recruitment manoeuvre performed 9.8 (965/9813)
FiO2 0.52 [0.45 to 0.70]
<0.40 7.1 (699/9808)
0.40 to <0.60 51.7 (5068/9808)
0.60 to <0.80 29.5 (2895/9808)
0.80 11.7 (1146/9808)
SpO2% 99.0 [98.0 to 100.0]
96 97.6 (9583/9817)
>90 to <96 2.3 (222/9817)
90 0.1 (12/9817)
EtCO2-kPa 4.5 [4.1 to 4.9]
Low versus increased risk of PPCs, according to the Assess Respiratory Risk in Surgic
are presented as median [LQ to UQ] or % (CI); x2 for categorical variables and Mann-W
jet ventilation, synchronised intermittent mandatory ventilation (SIMV). ABW, actual bo
152.4)) for males and 45.5 þ [0.91  (cm height  152.4)] for females; Cdyn, calcula
Cq.stat, static respiratory compliance; FiO2, fractional inspired oxygen; LQ, lower q
subgroup; Ppeak, peak pressure; Pplat, Plateau pressure; PEEP, positive end-expirato
Eur J Anaesthesiol 2017; 34:492–507CI 4.32 to 15.08), P< 0.001) and longer lengths of hospital
stay (4 [1 to 7] versus 1 [0 to 3] days, P< 0.001) (Table 5,
Fig. 4a to c).
Multivariable model to quantify the net effect of
intraoperative ventilation settings
Ventilation practice in patients who did and who did
not develop PPCs is presented in Table 6. The only
intraoperative variables associated with the occurrence
of PPCs were the peak pressure [OR 1.03 (95% CI 1.01
to 1.06), P¼ 0.013] and SpO2 [OR 0.84 (95% CI 0.78
to 0.91), P< 0.001]. Preoperative variables associated
with increased risk of PPCs were age, American Society
of Anaesthesiology (ASA) status, obstructive sleep
apnoea, and emergency or urgent surgery. Restricting
the PPC endpoint to more severe PPCs (by ignoring
unplanned supplementary oxygen) did not change
these results for either peak pressure [OR 1.04
(95% CI 1.0 to 1.08), P¼ 0.012] or SpO2 [OR 0.84
(95% CI 0.75 to 0.94), P¼ 0.002]. Preoperative
variables associated with increased risk of severe
PPCs were sex, metastatic cancer, obstructive sleepauthorized reproduction of this article is prohibited.
Low risk of PPCs Increased risk of PPCs P
69.0 (4589/6649) 72.7 (1910/2629) <0.001
17.5 (1161/6649) 13.6 (358/2629)
1.3 (87/6649) 0.6 (16/2629)
12.2 (812/6649) 13.1 (345/2629)
77.0 (5194/6742) 95.5 (2550/2670) <0.001
1.4 (97/6742) 0.8 (21/2670)
20.6 (1386/6742) 2.7 (72/2670)
1.0 (65/6742) 1.0 (27/2670)
00.0 [454.0 to 553.0] 500.0 [460.0 to 562.5] 0.017
8.1 [7.2 to 9.1] 8.2 [7.4 to 9.2] 0.001
6.7 [5.8 to 7.7] 6.7 [5.8 to 7.6] 0.354
3.0 [0.0 to 5.0] 4.5 [2.0 to 5.0] <0.001
12.0 [12.0 to 13.0] 12.0 [12.0 to 13.0] 0.205
6000 [5185 to 6816] 6000 [4979 to 6870] 0.003
17.0 [14.5 to 20.0] 19.0 [16.0 to 22.0] <0.001
15.0 [13.0 to 18.0] 17.0 [14.0 to 20.0]) <0.001
12.0 [10.0 to 15.0] 13.0 [10.0 to 16.0] <0.001
35.4 [28.6 to 43.5] 33.5 [27.1 to 41.1] <0.001
42.3 [34.3 to 52.0] 40.0 [32.0 to 50.0] <0.001
8.5 (570/6719) 12.9 (343/2656) <0.001
0.54 [0.47 to 0.72] 0.50 [0.45 to 0.60] <0.001
6.5 (440/6727) 9.0 (240/2660) <0.001
48.9 (3288/6727) 60.5 (1609/2660)
32.0 (2156/6727) 22.5 (599/2660)
12.5 (843/6727) 8.0 (212/2660)
99.0 [98.0 to 100.0] 99.0 [98.0 to 100.0] 0.198
97.8 (6571/6721) 97.0 (2573/2652) 0.040
2.1 (140/6721) 2.9 (77/2652)
0.1 (10/6721) 0.1 (2/2652)
4.5 [4.1 to 4.9] 4.4 [4.0 to 4.8] <0.001
al Patients in Catalonia (ARISCAT) risk score (<26 versus26, respectively). Data
hitney for continuous variables. a Other (e.g. high frequency oscillatory ventilation,
dy weight; PBW, predicted body weight, calculated as: 50þ (0.91 (cm height –
ted dynamic respiratory compliance, calculated as [tidal volume/(Ppeak  PEEP)];
uartile; UQ, upper quartile; n, number with characteristic; N, number in group or
ry pressure; SpO2, peripheral oxygen saturation; EtCO2, expiratory carbon dioxide.
Cop
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Ventilation parameters in patients at increased vs. patients at low risk of PPCs. (a) Cumulative frequency distribution of tidal volume; (b) cumulative
frequency distribution of positive end-expiratory pressure; (c) cumulative distribution of peak pressure; (d) cumulative distribution of driving pressure.
PBW, predicted body weight; PEEP, positive end-expiratory pressure; PPC, postoperative pulmonary complications; VT, tidal volume.apnoea, emergency or urgent surgery, and laparoscopic
surgery (Table 7).
Post-hoc analyses
To provide more insight into the effects of stratification
using the three original ARISCAT risk groups, we ana-
lysed the data according to the original boundaries
(eTables 6, 7, 8, http://links.lww.com/EJA/A119 Fig. 5,
and eFigures 1, 2, http://links.lww.com/EJA/A119). The
incidence of PPCs, mortality rates, and duration of stay in
hospital significantly increased from the lowest to the
highest risk group (eTable 8, http://links.lww.com/EJA/
A119).
Discussion
This prospective observational study with centres from
30 different countries shows that a substantial proportion
of patients undergoing invasive ventilation are at risk of
development of PPCs. These patients receive higher VT
and higher PEEP levels compared with patients at low
risk, but the differences are small. Only a minority of
patients receive intraoperative ventilation with VT lessyright © European Society of Anaesthesiology. Uthan 8 ml kg1 PBW and a PEEP level more than
5 cmH2O. The incidence of PPCs is high, and higher
in patients at increased risk. Patients at risk of PPCs have
longer lengths of hospital stay and increased in-hospital
mortality.
To our knowledge, the LAS VEGAS study is the largest
prospective investigation describing intraoperative venti-
lation strategies and the incidence of intraoperative
events and PPCs to date. The study is also the first to
show the incidence of surgical patients at increased risk of
PPCs using the ARISCAT score on a truly international
basis.17 The international character of this study
represents practice in many countries. The 1-week
prospective design of LAS VEGAS avoided the effects
of changes over time as the data were collected within a
short period. The findings of LAS VEGAS could help to
guide hypotheses for future trials of intraoperative venti-
lation and the data could be employed to support sample
size calculation for such a study of PPCs. It should be
stressed that the design of the current study excludes the
possibility of determining cause–effect relationships andnauthorized reproduction of this article is prohibited.
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Scatterplots showing distribution of (a) tidal volume with positive end-expiratory pressure combinations; (b) tidal volume with peak pressure; (c) tidal
volume with driving pressure; (d) tidal volume with respiratory rate in patients at increased vs. patients at low risk of PPCs. bpm, breaths per minute;
PBW, predicted body weight; PEEP, positive end-expiratory pressure; PPC, postoperative pulmonary complications; VT, tidal volume.does not allow the defining of any pathophysiological
associations with the outcome measures.
ARISCAT is an internally and externally validated score
for risk stratification that uses seven easy to obtain objec-
tive factors. The incidence of patients at increased risk of
PPCs in LAS VEGAS was comparable to that in the
original ARISCAT studies.17,18 In addition, the proportion
of patients at moderate and at high risk of PPCs who
developed one or more PPCs was similar to the original
studies.17,18ight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2017; 34:492–507LAS VEGAS extends our knowledge of the practice of
intraoperative ventilation, as it is the first study to explore
the use of intraoperative ventilator settings, not only in
patients at increased risk of PPCs, but also in patients at
low risk. Our results show remarkably little difference in
ventilation practice between these two patient categories
and indicate that protective ventilation (i.e. using a
combination of low VT and higher PEEP levels) is not
in widespread use. Notably, recent observational studies
in critically ill patients with or without ARDS also show
strikingly similar distributions of VT-size.
6,7authorized reproduction of this article is prohibited.
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Table 4 Intraoperative events
Variable All patients Low risk of PPCs Increased risk of PPCs Relative Risk (95% CI) P
Any de-saturation 3.9 (387/9844) 3.3 (219/6736) 5.6 (150/2658) 1.78 (1.44 to 2.20) <0.001
Unplanned recruitment manoeuvre 3.4 (332/9837) 2.5 (171/6731) 5.6 (148/2657) 2.26 (1.81 to 2.83) <0.001
Ventilatory pressure reduction 2.9 (282/9830) 2.2 (147/6730) 4.6 (122/1651) 2.16 (1.69 to 2.76) <0.001
Expiratory flow limitation 0.5 (52/9786) 0.4 (25/6703) 0.9 (24/2635) 2.45 (1.40 to 4.31) 0.001
Hypotension 26.6 (2617/9845) 23.7 (1594/6737) 35.3 (939/2659) 1.76 (1.60 to 1.94) <0.001
Vasoactive drugs 22.4 (2208/9845) 18.5 (1246/6737) 33.7 (897/2659) 2.24 (2.03 to 2.48) <0.001
New arrhythmias 0.6 (60/9838) 0.4 (24/6732) 1.2 (32/2657) 3.41 (2.00 to 5.79) <0.001
Low versus increased risk of PPCs, according to the Assess Respiratory Risk in Surgical Patients in Catalonia risk (ARISCAT) score (<26 versus26, respectively). Data
are presented as % (n/N). Comparison of differences within a subgroup is performed by using the t-test for continuous variables and x2 for categorical variables. CI,
confidence interval; n, number with characteristic; PPC, postoperative pulmonary complication; N, number in group or subgroup. Definitions of intraoperative events: Any
de-saturation, defined as the occurrence of SpO2 <92%; unplanned recruitment manoeuvre, ventilation strategies aimed at restoring lung aeration; ventilation pressure
reduction, ventilation strategies aimed at lowering peak and/or plateau pressures; expiratory flow limitation, defined as expiratory flow higher than zero at end-expiration as
suggested by visual analysis of the expiratory gas flow curve; hypotension, defined as systolic arterial pressure <90 mmHg for 3 min or longer; need for vasoactive drugs,
defined as any vasoactive drug given to correct hypotension; new-onset arrhythmias, defined as new onset of atrial fibrillation, sustained ventricular tachycardia,
supraventricular tachycardia, or ventricular fibrillation.
Table 5 Patient outcomes
Variable All patients Low risk of PPCs Increased risk of PPCs Relative Risk (95% CI) P
Postoperative pulmonary complications
Total PPCsa 10.4 (1004/9697) 7.0 (467/6675) 19.2 (505/2632) 3.16 (2.76 to 3.61) <0.001
Unplanned supplemental O2
b 8.5 (826/9697) 5.8 (390/6675) 15.5 (408/2632) 2.96 (2.55 to 3.42) <0.001
Respiratory failure 1.6 (156/9697) 0.9 (60/6675) 3.4 (90/2632) 3.90 (2.81 to 5.43) <0.001
Invasive MV 1.1 (107/9697) 0.6 (41/6675) 2.3 (61/2632) 3.84 (2.58 to 5.72) <0.001
ARDS 0.1 (9/9697) 0.0 (1/6675) 0.3 (8/2632) 20.35 (2.54 to 162.76) <0.001
Pneumonia 0.4 (40/9697) 0.1 (10/6675) 1.1 (28/2632) 7.17 (3.48 to 14.77) <0.001
Pneumothorax 0.1 (13/9697) 0.1 (8/6675) 0.2 (4/2632) 1.27 (0.38 to 4.23) 0.697
Postoperative outcome
Length of hospital stay 1.0 [0.0 to 4.0] 1.0 [0.0 to 3.0] 4.0 [1.0 to 7.0] - <0.001
In-hospital mortality 0.6 (56/8973) 0.2 (13/6163) 1.7 (41/2445) 8.07 (4.32 to 15.08) <0.001
Hospital-free daysc 26.0 [23.0 to 27.0] 26.0 [24.0 to 27.0] 23.0 [21.0 to 26.0] - <0.001
Low versus increased risk of PPCs, according to the Assess Respiratory Risk in Surgical Patients in Catalonia (ARISCAT) risk score (<26 versus26, respectively). Data
are presented as proportion, % (n/N) or median [LQ UQ]. Comparison of differences within a subgroup is performed by using the t-test for continuous variables and x2
for categorical variables. ARDS, acute respiratory distress syndrome; CI, confidence interval; LOS, length of hospital stay; LQ, lower quartile; MV, mechanical ventilation;
N, number in group or subgroup; n, number with characteristic; NIV, noninvasive ventilation by mask or helmet; PPCs, Postoperative pulmonary complications; PPCs: on
day 1 to 5 were scored YES as soon as the event occurred on either ward or intensive care unit; UQ, upper quartile. a Total PPCs: one patient could present with multiple
PPCs but was scored only once (YES or NO principle). b unplanned supplementary O2: supplemental oxygen administered due to PaO2<8 kPa or SpO2<90% in room
air, excluding oxygen supplementation given as standard care (e.g. directly after arrival in the Post Anaesthesia Care Unit. c Hospital-free days when discharged and alive at
day 28.
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Outcome in patients at increased vs. patients at low risk of PPCs. (a) Probability of development of PPCs; (b) probability of hospital discharge; and
(c) probability of in-hospital mortality. PPC, postoperative pulmonary complications.
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Table 6 Univariable and multivariable analyses using PPC as outcome
Univariable analyses Multivariable analyses
PPC (nU1004) No PPC (nU8693) P OR (95% CI) P OR (95% CI) P
Ventilatory parameters
Tidal volume (ml kg1 PBW) 8.0 [7.2 to 9.1] 8.1 [7.2 to 9.1] 0.425 1.01 (0.96 to 1.05) 0.694 0.97 (0.90 to 1.05) 0.501
PEEP (cmH2O) 4 [2 to 5] 3 [0 to 5] <0.001 1.12 (1.09 to 1.15) <0.001 1.02 (0.97 to 1.08) 0.343
Peak pressure (cmH2O) 18 [16 to 22] 17 [15 to 21] <0.001 1.05 (1.04 to 1.06) <0.001 1.03 (1.01 to 1.06) 0.013
Plateau pressure (cmH2O)
a 17 [14 to 20] 15 [13 to 18] <0.001 1.07 (1.05 to 1.09) <0.001 - -
Driving pressure (cmH2O)
a 13 [10 to 16] 12 [10 to 15] 0.002 1.04 (1.02 to 1.06) <0.001 - -
FiO2 (%) 50 [45 to 65] 51 [45 to 70] <0.001 0.99 (0.99 to 0.99) <0.001 1.00 (0.99 to 1.01) 0.152
Respiratory rate (bpm) 12 [12 to 13] 12 [12 to 13] 0.485 1.01 (0.98 to 1.04) 0.628 0.99 (0.92 to 1.06) 0.752
Patient characteristics
Male sex 468/1004 (46.6) 3887/8693 (44.7) 0.251 1.08 (0.95 to 1.23) 0.252 - -
Age (years) 61 [47 to 71] 53 [39 to 65] <0.001 1.02 ((.02 to 1.03) <0.001 1.02 (1.01 to 1.02) <0.001
50 301/1004 (30.0) 4025/8690 (46.3)
51 to 80 628/1004 (62.5) 4357/8690 (50.1) <0.001 - - - -
>80 75/1004 (7.5) 308/8690 (3.5)
BMI (kg m2) 26.9 [23.9 to 30.5] 26.2 [23.3 to 29.9] <0.001 1.02 (1.01 to 1.04) <0.001 1.00 (0.99 to 1.02) 0.739
ASA 2 [2 to 3] 2 [1 to 2] <0.001 1.74 (1.60 to 1.89) <0.001 1.36 (1.11 to 1.66) 0.003
1 188/1000 (18.8) 2745/8674 (31.6)
2 441/1000 (44.1) 4245/8674 (48.9)
3 332/1000 (33.2) 1547/8674 (17.8) <0.001 - - - -
4 38/1000 (3.8) 130/8674 (1.5)
5 1/1000 (0.1) 7/8674 (0.1)
Functional status
Independent 863/1002 (86.1) 8090/8689 (93.1) <0.001 1 (Reference) 1 (Reference)
Partially dependent 120/1002 (12.0) 489/8689 (5.6) 2.30 (1.86 to 2.84) <0.001 1.26 (0.85 to 1.86) 0.249
Totally dependent 19/1002 (1.9) 110/8689 (1.3) 1.62 (0.99 to 2.65) 0.055 1.31 (0.70 to 2.46) 0.394
Smoker 190/1003 (18.9) 2058/8690 (23.7) <0.001 0.75 (0.64 to 0.89) <0.001 0.93 (0.76 to 1.15) 0.516
ARISCAT score 26 [15 to 40] 15 [3 to 26] <0.001 1.04 (1.03 to 1.04) <0.001 1.01 (1.00 to 1.02) 0.058
<26 467/972 (48.0) 6208/8335 (74.5)
26 to 44 385/972 (39.6) 1799/8335 (21.6) <0.001 - - - -
>44 120/972 (12.3) 328/8335 (3.9)
Preoperative SpO2 (%) 97 [95 to 99] 98 [96 to 99] <0.001 0.88 (0.86 to 0.91) <0.001 0.98 (0.93 to 1.03) 0.405
96 659/902 (73.1) 6482/7656 (84.7)
91 to 95 208/902 (23.1) 1101/7656 (14.4) <0.001 - - - -
 90 35/902 (3.9) 73/7656 (1.0)
Preoperative anaemia 62/897 (6.9) 256/7247 (3.5) <0.001 2.03 (1.52 to 2.70) <0.001 1.56 (0.97 to 2.53) 0.068
Chronic comorbidity
Metastatic cancer 89/1004 (8.9) 299/8693 (3.4) <0.001 2.73 (2.13 to 3.49) <0.001 1.25 (0.89 to 1.76) 0.193
Chronic kidney dysfunction 59/1004 (5.9) 248/8693 (2.9) <0.001 2.13 (1.59 to 2.85) <0.001 1.25 (0.87 to 1.79) 0.227
COPD 94/1004 (9.4) 494/8693 (5.7) <0.001 1.71 (1.36 to 2.16) <0.001 1.34 (0.92 to 1.95) 0.132
Heart failure 86/1004 (8.6) 488/8693 (5.6) <0.001 1.57 (1.24 to 2.00) <0.001 0.95 (0.68 to 1.33) 0.783
Obstructive sleep apnoea 39/1004 (3.9) 166/8693 (1.9) <0.001 2.08 (1.46 to 2.96) <0.001 2.45 (1.42 to 4.23) 0.001
Neuromuscular diseaseb 12/1004 (1.2) 75/8693 (0.9) 0.290 1.39 (0.75 to 2.57) 0.292 - -
Liver dysfunction 9/1004 (0.9) 88/8693 (1.0) 0.726 0.88 (0.44 to 1.76) 0.727 - -
Surgical characteristics
Urgency of surgeryc
Elective 836/1004 (83.3) 7806/8691 (89.8) <0.001 1 (Reference) 1 (Reference)
Urgency 125/1004 (12.5) 691/8691 (8.0) 1.69 (1.38 to 2.07) <0.001 1.62 (1.14 to 2.29) 0.007
Emergency 43/1004 (4.3) 194/8691 (2.2) 2.07 (1.48 to 2.90) <0.001 3.01 (1.64 to 5.53) <0.001
Type of incision
Peripheral 454/1004 (45.2) 5026/8693 (57.8) <0.001 1 (Reference) 1 (Reference)
Abdominal 550/1004 (54.8) 3667/8693 (42.2) 1.66 (1.46 to 1.89) <0.001 1.05 (0.73 to 1.52) 0.777
Type of surgery
Nonlaparoscopic 821/1004 (81.8) 7004/8693 (80.6) 0.360 1 (Reference) 0.361 - -
Laparoscopic 183/1004 (18.2) 1689/8693 (19.4) 0.92 (0.78 to 1.09)
Duration of surgery (min)d 109 [60 to 180] 70 [0 to 119] <0.001 1.00 (1.00 to 1.00) <0.001 1.00 (0.99 to 1.01) 0.265
Duration of anaethesia (min)e 145 [93 to 230] 100 [65 to 154] <0.001 1.00 (1.00 to 1.00) <0.001 1.00 (0.99 to 1.01) 0.270
Intraoperative characteristics
Tube type
Endotracheal 885/1003 (88.2) 7045/8688 (81.1) 1 (Reference) 1 (Reference)
Nasotracheal 12/1003 (1.2) 114/8688 (1.3) 0.83 (0.46 to 1.52) 0.563 1.42 (0.40 to 5.01) 0.589
Supra-glottic 94/1003 (9.4) 1445/8688 (16.6) 0.52 (0.42 to 0.64) <0.001 0.78 (0.54 to 1.12) 0.174
Other 12/1003 (1.2) 84/8688 (1.0) 1.14 (0.62 to 2.09) 0.679 0.86 (0.31 to 2.40) 0.775
Ventilation mode
VCV 705/991 (71.1) 5994/8564 (70.0) 1 (Reference) 1 (Reference)
PCV 185/991 (18.7) 1368/8564 (16.0) 0.005 1.15 (0.97 to 1.37) 0.112 1.13 (0.85 to 1.49) 0.395
Assisted 44/991 (4.4) 578/8564 (6.7) 0.65 (0.47 to 0.88) 0.007 0.90 (0.45 to 1.82) 0.774
Otherf 57/991 (5.8) 624/8564 (7.3) 0.78 (0.59 to 1.03) 0.079 0.93 (0.56 to 1.53) 0.772
SpO2 (%) 99 [98 to 100] 99 [98 to 100] <0.001 0.87 (0.83 to 0.91) <0.001 0.84 (0.78 to 0.91) <0.001
EtCO2 (kPa) 4.5 [4.1 to 4.9] 4.5 [4.1 to 4.8] 0.083 1.00 (0.99 to 1.01) 0.273 - -
Transfusion of PRBC 84/1004 (8.4) 237/8693 (2.7) <0.001 3.26 (2.52 to 4.22) <0.001 1.51 (0.95 to 2.41) 0.081
Data are presented as median [LQ  UQ] or n/N (%); driving pressure¼plateau pressure-PEEP. a Plateau pressure and driving pressure were only reported and
calculable in 60% of all patients. Peak pressure, plateau pressure, and driving pressure had high collinearity, therefore only peak pressure was entered into the model, as
plateau pressure had missing values.ASA, American Society of Anaesthesiology; ARISCAT, Assess Respiratory Risk in Surgical Patients in Catalonia risk score; bpm,
breaths per minute; CI, confidence interval; COPD, Chronic Obstructive Pulmonary Disease; EtCO2: expired carbon dioxide; FiO2, inspired fraction of oxygen; LQ, lower
quartile; OR: odds ratio; PBW, predicted body weight; PEEP, positive end-expiratory pressure; PPC, composite endpoint of postoperative pulmonary complications;
PRBC, packed red blood cells; SpO2, peripheral oxygen saturation; UQ, upperquartile.
b Neuromuscular disease affecting the respiratory system. c Urgency of surgery:
elective: surgery that is scheduled in advance because it does not involve a medical emergency, urgent: surgery required within <48 h, emergency: nonelective surgery
performed when the patient’s life or well being is in direct jeopardy. d Duration of surgery is the time between skin incision and closure of the incision. e Duration of
anaesthesia is the time between start induction and extubation or discharge from operation room if mechanical ventilation remained. f Other (e.g. high frequency oscillatory
ventilation, jet ventilation, synchronised intermittent mandatory ventilation).
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Table 7 Univariable and multivariable analyses using severe PPC as outcome
Univariable analyses Multivariable analyses
Severe PPC (nU1004) No PPC (nU8693) P OR (95% CI) P OR (95% CI) P
Ventilator settings
Tidal volume (ml kg1 PBW) 8.0 [7.2 to 8.9] 8.1 [7.2 to 9.1] 0.580 1.01 (0.94 to 1.10) 0.722 0.96 (0.84 to 1.11) 0.621
PEEP (cmH2O) 4 [2 to 5] 3 [0 to 5] <0.001 1.11 (1.06 to 1.17) <0.001 0.95 (0.88 to 1.02) 0.153
Peak pressure (cmH2O) 18 [16 to 22] 17 [15 to 21] <0.001 1.05 (1.03 to 1.07) <0.001 1.04 (1.01 to 1.08) 0.012
Plateau pressure (cmH2O)
a 17 [15 to 20] 15 [13 to 18] <0.001 1.06 (1.03 to 1.09) <0.001 - -
Driving pressure (cmH2O)
a 13 [11 to 16] 12 [10 to 15] 0.001 1.04 (1.01 to 1.08) 0.009 - -
FiO2 (%) 50 [42 to 60] 51 [45 to 70] 0.001 0.99 (0.98 to 0.99) <0.001 1.01 (0.99 to 1.02) 0.080
Respiratory rate (bpm) 12 [12 to 13] 12 [12 to 13] 1.03 (0.98 to 1.09) 0.204 1.00 (0.91 to 1.11) 0.944
Patient characteristics
Male sex 152/270 (56.3) 4203/9427 (44.6) <0.001 1.60 (1.25 to 2.04) <0.001 0.036
Age (years) 59 [45 to 69] 53 [40 to 66] <0.001 1.02 (1.01 to 1.02) <0.001 0.99 (0.99 to 1.01) 0.825
 50 88/270 (32.6) 4238/9424 (45.0)
51 to 80 164/270 (60.7) 4821/9424 (51.2) <0.001 - - - -
>80 18/270 (6.7) 365/9424 (3.9)
BMI (kg m2) 26.1 [23.2 to 29.9] 26.2 [23.4 to 30.0] 0.998 1.02 (0.99 to 1.04) 0.065 1.00 (0.98 to 1.03) 0.726
ASA 2 [2 to 3] 2 [1 to 2] <0.001 2.00 (1.69 to 2.29) <0.001 1.14 (0.87 to 1.49) 0.353
1 49/269 (18.2) 2884/9405 (30.7)
2 101/269 (37.5) 4585/9405 (48.8)
3 101/269 (37.5) 1778/9405 (18.9) <0.001 - - - -
4 17/269 (6.3) 151/9405 (1.6)
5 1/269 (0.4) 7/9405 (0.1)
Functional status
Independent 224/270 (83.0) 8729/9421 (92.7) <0.001 1 (Reference) 1 (Reference)
Partially dependent 36/270 (13.3) 573/9421 (6.1) 2.45 (1.70 to 3.52) <0.001 1.26 (0.69 to 2.29) 0.451
Totally dependent 10/270 (3.7) 119/9421 (1.3) 3.27 (1.69 to 6.33) <0.001 1.70 (0.59 to 4.85) 0.324
Smoker 60/270 (22.2) 2188/9423 (23.2) 0.701 0.94 (0.71 to 1.26) 0.702 - -
ARISCAT score 27 [16 to 41] 15 [3 to 26] <0.001 1.04 (1.04 to 1.05) <0.001 1.01 (0.99 to 1.03) 0.165
<26 104/260 (40.0) 6571/9047 (72.6)
26 to 44 115/260 (44.2) 2069/9047 (22.9) <0.001 - - - -
>44 41/260 (15.8) 407/9047 (4.5)
Preoperative SpO2 (%) 97 [95 to 99] 98 [96 to 99] 0.010 0.93 (0.89 to 0.97) <0.001 0.99 (0.91 to 1.08) 0.842
96 180/242 (74.4) 6961/8316 (83.7)
91 to 95 48 242 (19.8) 1261/8316 (15.2) <0.001 - - - -
90 14 242 (5.8) 94/8316 (1.1)
Preoperative anaemia 25/259 (9.7) 293/7885 (3.7) <0.001 2.77 (1.80 to 4.25) <0.001 1.83 (0.89 to 3.75) 0.098
Chronic co-morbidity
Metastatic cancer 38/270 (14.1) 350/9427 (3.7) <0.001 4.25 (2.97 to 6.08) <0.001 2.16 (1.28 to 3.62) 0.004
Chronic kidney dysfunction 16/270 (5.9) 291/9427 (3.1) 0.008 1.98 (1.18 to 3.32) <0.001 1.15 (0.64 to 2.05) 0.643
COPD 35/270 (13.0) 553/9427 (5.9) <0.001 2.39 (1.66 to 3.44) <0.001 1.50 (0.90 to 2.51) 0.118
Heart failure 28/270 (10.4) 546/9427 (5.8) 0.001 1.88 (1.26 to 2.81) 0.002 1.32 (0.75 to 2.31) 0.327
Obstructive sleep apnoea 18/270 (6.7) 187/9427 (2.0) <0.001 3.53 (2.14 to 5.82) <0.001 3.53 (1.72 to 7.26) 0.001
Neuromuscular diseaseb 3/270 (1.1) 84/9427 (0.9) 0.705 1.25 (0.39 to 3.98) 0.706 - -
Liver dysfunction 3/270 (1.1) 94/9427 (1.0) 0.852 1.12 (0.35 to 3.54) 0.853 - -
Surgical characteristics
Urgency of surgeryc
Elective 195/270 (72.2) 8447/9425 (89.6) <0.001 1 (Reference) 1 (Reference)
Urgency 52/270 (19.3) 764/9425 (8.1) 2.95 (2.15 to 4.04) <0.001 2.56 (1.64 to 3.99) <0.001
Emergency 23/270 (8.5) 214/9425 (2.3) 4.66 (2.96 to 7.32) <0.001 5.83 (2.74 to 12.37) <0.001
Type of incision
Peripheral 111/270 (41.1) 5369/9427 (57.0) <0.001 1 (Reference) 1 (Reference)
Abdominal 159/270 (58.9) 4058/9427 (43.0) 1.89 (1.48 to 2.42) <0.001 1.18 (0.73 to 1.89) 0.501
Type of surgery
Nonlaparoscopic 230/270 (85.2) 7595/9427 (80.6) 0.057 1 (Reference) 1 (Reference)
Laparoscopic 40/270 (14.8) 1832/9427 (19.4) 0.72 (0.51 to 1.01) 0.059 0.49 (0.27 to 0.86) 0.014
Duration of surgery (min)d 115 [63 to 200] 71 [40 to 121] <0.001 1.00 (1.00 to 1.00) <0.001 1.00 (0.99 to 1.01) 0.644
Duration of anaethesia (min)e 155 [63 to 200] 100 [65 to 160] <0.001 1.00 (1.00 to 1.00) <0.001 1.00 (0.99 to 1.01) 0.328
Intraoperative characteristics
Tube type
Endotracheal 246/270 (91.1) 7684/9421 (81.6) 1 (Reference) 1 (Reference)
Nasotracheal 4/270 (1.5) 122/9421 (1.3) 1.02 (0.37 to 2.79) 0.963 1.65 (0.44 to 6.21) 0.458
Supra-glottic 16/270 (5.9) 1523/9421 (16.2) 0.33 (0.20 to 0.55) <0.001 0.57 (0.29 to 1.12) 0.103
Other 4/270 (1.5) 92/9421 (1.0) 1.36 (0.49 to 3.72) 0.552 0.81 (0.11 to 6.21) 0.843
Ventilation mode
Volume controlled 181/267 (67.8) 6518/9288 (70.2) 1 (Reference) 1 (Reference)
Pressure controlled 55/267 (20.6) 1498/9288 (16.1) 0.237 1.32 (0.97 to 1.80) 0.075 1.07 (0.71 to 1.61) 0.740
Assisted 15/267 (5.6) 607/9288 (6.5) 0.89 (0.52 to 1.52) 0.668 1.50 (0.67 to 3.34) 0.322
Otherf 16/267 (6.0) 665/9288 (7.2 0.87 (0.52 to 1.45) 0.587 1.54 (0.76 to 3.11) 0.226
SpO2 (%) 99 [98 to 100] 99 [98 to 100] 0.489 0.94 (0.86 to 1.02) 0.135 0.84 (0.75 to 0.94) 0.002
EtCO2 (kPa) 4.4 [4.0 to 4.8] 4.5 [4.1 to 4.9] 0.001 0.96 (0.94 to 0.99) 0.005 1.03 (0.98 to 1.08) 0.238
Transfusion of PRBC 39/270 (14.4) 282/9427 (3.0) <0.001 5.47 (3.82 to 7.84) <0.001 1.82 (1.08 to 3.05) 0.024
Data are presented as median [LQ to UQ] or n/N (%). Driving pressure¼plateau pressure  PEEP. ASA, American Society of Anaesthesiology; ARISCAT, Assess
Respiratory Risk in Surgical Patients in Catalonia risk score; bpm, breaths per minute; CI, confidence interval; COPD, chronic obstructive pulmonary disease; EtCO2,
expiratory carbon dioxide; FiO2, inspired fraction of oxygen; LQ, lower quartile; OR, odds ratio; PBW, predicted body weight; PEEP, positive end-expiratory pressure; PPC,
composite endpoint of postoperative pulmonary complications; severe PPCs, same composite as total PPCs, without unplanned supplemental O2; PRBC, packed red
blood cells; OR, odds ratio; SpO2, peripheral oxygen saturation; UQ, upper quartile.
a Plateau pressure and driving pressure was only reported and calculable in 60% of all
patients; Peak pressure, plateau pressure, and driving pressure had high co-linearity, therefore only peak pressure was entered into the model, as plateau pressure had
missing values. b Neuromuscular disease affecting the respiratory system. c Urgency of surgery: elective, surgery that is scheduled in advance because it does not involve a
medical emergency; urgent, surgery required within<48 h; emergency, nonelective surgery performed when the patient’s life or well being is in direct jeopardy. d Duration
of surgery is the time between skin incision and closure of the incision. e Duration of anaesthesia is the time between start induction and extubation or discharge from
operation room if mechanical ventilation remained. f Other (e.g. high frequency oscillatory ventilation, jet ventilation, synchronised intermittent mandatory ventilation).
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Outcome in patients at low, moderate, and high risk of PPCs: (a) probability of development of PPCs; (b) probability of hospital discharge; and (c)
probability of in-hospital mortality. PPC, postoperative pulmonary complications.The current results also confirm previous reports of
ventilation practice in the surgical setting: previous audits
and retrospective studies of intraoperative ventilation
showed that surgical patients continue to receive venti-
lation with high VT.
25–27 These studies, however, did not
compare ventilation practice in different risk groups. The
results from LAS VEGAS suggest that VT has reduced
when compared with earlier studies, at least in the
participating centres. This finding is in line with recent
findings in a prospective study in patients with high ASA
scores.28 Interestingly, VT was not a predictor for the
development PPCs, a finding similar to the results of a
previous observational study.29
Our results suggest that there are two preferences with
regard to the PEEP level during intraoperative venti-
lation as the most frequently chosen levels were 0 and
5 cmH2O. PEEP levels more than 5 cmH2O were rarely
used, even in patients at increased risk of PPCs. The
frequent use of PEEP levels equal to or lower than
5 cmH2O is comparable to reports from previous
studies.25–28 In the LAS VEGAS study no association
between PEEP levels and the occurrence of PPCs was
found, similar to a recent randomised controlled trial.30
In contrast to our results, three recent trials advocate the
use of higher PEEP levels for protective ventilation.9–11
The absence of a protective effect of higher PEEP
levels in our study could be explained by a possible
parabola-shaped association between PEEP and the
development of PPCs, as found in a previous analysis.29
In that study of electronic patient records, PEEP levels
less than 5 cmH2O and more than 5 cmH2O were associ-
ated with higher risk of PPCs, suggesting that a PEEP
level of 5 cmH2O would be most protective.
29 Second,
we did not examine specific operative procedures
whereas a recent study suggest that PEEP can have
different effects on PPCs, depending on the procedure
performed.31ight © European Society of Anaesthesiology. Un
Eur J Anaesthesiol 2017; 34:492–507Our study also indicates that high peak pressures
(>20 cmH2O) and high driving pressures (>12 cmH2O)
are used in many patients and, in particular, in patients at
increased risk of PPCs. Patients who developed PPCs
were ventilated with higher peak pressures, plateau
pressures, and driving pressures than patients who did
not develop PPCs. This mirrors two recent investigations
showing an association between increasing plateau press-
ures29 and the development of PPCs and between intrao-
perative changes in the driving pressure level and
occurrence of PPCs.32 Of interest, in LAS VEGAS higher
peak pressures seem to be associated with increased risk
of PPCs, when corrected for known risk factors.20–22 We
chose to limit the multivariable model to peak pressures,
as there was high co-linearity between peak pressure,
plateau pressure, and driving pressure. Intraoperative
SpO2 was also associated with development of PPCs.
This finding must be interpreted with caution, as SpO2
levels may have several confounders, even though the
model was corrected for preoperative SpO2, smoking,
chronic obstructive pulmonary disease, intraoperative
PEEP and FiO2. Nevertheless, it could be that patients
who develop hypoxaemia during surgery are at increased
risk of PPCs, suggesting that these patients may benefit
from more intensive postoperative monitoring. Although
the difference between the groups in the peak pressures
applied are small, it still could be of potential importance,
as the analysis suggests that for every increase of
1 cmH2O in peak pressure there is a 3% increase in
the odds ratio for the development of PPCs. Because
of the large number of surgical procedures in which a
patient requires intraoperative ventilation (approxi-
mately 234 million per year16), even a small rise in the
incidence of PPCs translates into a large number of
patients at risk.
Even though clinicians were not informed about the
subsequent use of ARISCAT score, we cannot excludeauthorized reproduction of this article is prohibited.
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PPCs, for example sicker patients with underlying lung
disease or obese patients, received or required adjusted
ventilator settings, while also developing PPCs more
often.
The composite endpoint of PPCs included ‘unplanned
supplementary oxygen’, a definition used in previous
clinical studies,17,18 and in a recent publication on stan-
dards for definitions and the use of outcome measures for
research into clinical effectiveness in perioperative medi-
cine.33 As unplanned supplementary oxygen could have
confounders, we excluded this from the composite end-
point for ‘severe PPCs’ in one post-hoc analysis. This
analysis showed similar results. Of note, a recently
published study showed that patients requiring pro-
longed postoperative oxygen had increased hospital
lengths of stay.28
In line with the abovementioned study,28 the results of
the current study confirm that patients who develop
PPCs have longer duration of hospital admission and
increased in-hospital mortality. Previously, the PERI-
SCOPE study showed that worsening patient outcomes
are associated with a rise in the number of PPCs.18
Furthermore, the probability of patient survival decreases
sharply with increasing severity of postoperative respir-
atory failure.34 These results were confirmed by two
recent large individual data meta-analyses, showing an
association between development of PPCs and longer
lengths of hospital stay, and increased mortality.14,15
Even though this study is not designed to evaluate the
relation between occurrence of PPCs and outcome, our
results mirror these earlier studies.14,15,18,34
Supraglottic devices were used markedly fewer times in
patients at increased risk of PPCs compared with patients
at low risk, which could have an effect on applied
ventilation strategies and outcome. However, when
entering supraglottic devices into the multivariable
model, the variable did not have an association with
development of PPCs.
The findings of this study suggest that more attention
should be given to protection of the lung from the
potentially harmful effects of intraoperative ventilation.
First, it seems that protective ventilation is not always
used during surgery. Second, although the results of this
study confirm previous findings that high inspiratory
and high driving pressures levels during intraoperative
ventilation could play major roles in the development of
PPCs,29,32 uncertainty regarding how to prevent such
high pressures remains. There is a need for feasibility
studies testing interventions aimed at low pressures, and
for randomised controlled trials that test whether such
strategies do have the potential to prevent PPCs in
surgical patients.35 Currently, several randomised
controlled trials are being conducted to investigate the
effect of protective ventilation in specific patientyright © European Society of Anaesthesiology. Upopulations, such as the PROBESE trial in obese patients
(Clinical trials.gov identifier: NCT02148692, https://clin
icaltrials.gov/ct2/show/NCT02148692?term=NCT02148692
&rank=1), the PROTHOR trial in patients under-
going one-lung ventilation (Clinicaltrials.gov identi-
fier: NCT02963025, https://clinicaltrials.gov/ct2/show/
NCT02963025?term=NCT02963025&rank=1), and the
AVATaR trial in patients undergoing robotic surgery
(Clinicaltrials.gov identifier: NCT02989415, https://clini
caltrials.gov/ct2/show/NCT02989415?term=NCT02989415
&rank=1).
The LAS VEGAS study has several limitations. First, the
willingness of participating centres to join the study may
have resulted in a selection bias towards those centres
with an interest in protective ventilation, meaning that
they may already use low VT during general anaesthesia
for surgery. Second, any prospective observational study
can interfere with daily practice, making anaesthetists
more likely to use those ventilation settings that are
considered to be lung-protective. Third, due to the
selection of centres participating in this study, the results
may not be representative of ventilation management in
the different countries. Fourth, there was no restriction
on the number of centres per country and, with the
number of centres per country ranging from 1 to 19, this
could have biased the results. Fifth, it is possible that
there was a quality difference in data reporting between
the centres despite extensive data cleaning. Sixth, the
design of the study only allowed the recording of data
collected as part of standard care and thus, we were
required to restrict our collection of postoperative pul-
monary complications to those that could be captured
easily in all patients, without ordering extra laboratory or
radiographic examinations. Last, although the large num-
ber of PPC events permitted a high number of variables
in our analysis,36 the large exploratory multivariate model
has its potential limitations and should not be used for
cause–effect determination.
Conclusion
The incidence of patients at risk of PPCs is high. A large
proportion of patients receive high VT and low PEEP
levels, seemingly independent of the risk of PPCs.
Patients at increased risk more frequently develop PPCs,
have longer lengths of hospital stay and increased in-
hospital mortality. These findings suggest that more
attention could be given to the use of lung-protective
modes during intraoperative mechanical ventilation in
patients at risk of PPCs.
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